2013-12-09

[DIV28SUPER] NYTimes: The Case for Tolerating E-Cigarettes

http://nyti.ms/1iO6fmr

No one believes that nicotine addiction is good, but efforts are best spent on minimizing the resulting harm.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2013-12-05

[DIV28SUPER] Travel Award for CPDD 2014

There’s still time to apply for NIDA’s Women & Sex Gender Differences Research Travel Award for Junior Investigators for CPDD 2014!  CPDD extended their abstract submission deadline to Dec 10 (http://www.cpdd.vcu.edu/  ) so we also extended our application deadline to Dec 10!   For application details see the attached travel award announcement (or  click here for that announcement) or contact Dr. Samia Noursi (snoursi@mail.nih.gov; 301-594-5622) or me.  Please share this email with potential applicants. 

 

Thanks,

Cora Lee Wetherington

 

Cora Lee Wetherington, Ph.D.

Women & Sex/Gender Differences Research Coordinator

Division of Clinical Neuroscience & Behavioral Research

National Institute on Drug Abuse

6001 Executive Blvd., Suite 3155, MSC 9593

Bethesda, MD 20892-9593 (For overnight mail:  Rockville, MD 20852) 

Phone:  (301) 435-1319

Fax:  (301) 443-6814

E-mail: cwetheri@nida.nih.gov

 

NIDA’S WOMEN & SEX/GENDER DIFFERENCES JUNIOR INVESTIGATOR TRAVEL AWARD PROGRAM for CPDD 2014:       

Deadline has been extended to Dec 10!  See  http://www.drugabuse.gov/sites/default/files/files/CallforAbstracts2014CPDDwithextendeddeadline%281%29.pdf

 

Standard Due Dates: http://grants.nih.gov/grants/funding/submissionschedule.htm

 

 

 

 

 

[DIV28SUPER] Concurrent Session Lineup at the 2014 CPA Conference

Trouble viewing this email? Visit our Website


2014 Collaborative Perspectives on Addiction
Atlanta, Georgia
Feb. 28 - March 1, 2014
Reserve Your Hotel | Conference Registration | Present a Poster
Download Registration Brochure

CONCURRENT SESSIONS

 

We have a great lineup of concurrent sessions being offered at the CPA conference. See below for an overview or go to http://www.tinyurl.com/2014CPA to view full session descriptions.

 

The Effects of Social Influence on Substance Use Behavior and Outcomes in Preclinical and Clinical Samples

Jodi Gilman, PhD; John F. Kelly, PhD; Allison Anacker, PhD

 

Working At the Crossroads: Clinical Findings from a Combined Medication and Psychotherapy Trial for Co-Occurring PTSD and AUD

Denise Hien, PhD; Lesia M. Ruglass, PhD; Teresa Lopez-Castro, PhD; Laura Eidlitz, EdM; Annelisa Pedersen, MPhil; Patricia Yoon, MA

 

Opioid Overdose: Intervention Efforts and Challenges

Kelly Dunn, PhD; Daniel Wermeling, PharmD; Maya Doe-Simkins, MPH; Dan Bigg, CRADC

 

Bringing Neuroscience Into Addiction Treatment Through Behavioral Interventions

Marsha Bates, PhD; Brandon Alderman, PhD; David Eddie, MS; Tracey Shors, PhD; Edward Selby, PhD

 

Steps Toward Success As An Early Career Addiction Psychologist

Katie Witkiewitz, PhD; John F. Kelly, PhD; Ellen Walker, PhD; Bill Stoops, PhD; James Murphy, PhD; James MacKillop, PhD; Lara Ray, PhD

 

Prescription Opioids: The Role of Efficacy, Pain Modalities, and Sex Differences in Reward States

Ellen Walker, PhD; Sandra Comer, PhD

 

Enhancing Brief Alcohol Interventions Using Translational Research and Mechanisms of Change Approaches

Ashley Dennhardt, PhD; Andrea R. Diulio, MS; Mark M. Silvestri, MS; James G. Murphy, PhD; Ali M. Yurasek, MS

 

 

ABOUT THE CONFERENCE

 

The theme for the 2014 CPA is "Changing Addictive Behavior: Bench to Bedside and Back Again"

·         Thought-provoking keynotes and cross-discipline panels

·         Interactive environment for collaboration/networking

·         Pre-Conference Workshop (see below)

·         Pre-Conference “Functional Integration” Session (see below)

·         Poster Sessions

·         Discounted rates for Early Career Psychologists

·         Student opportunities (discounted rates, special networking, etc.)

·         You don't have to be a member of either division or APA to attend the conference!

·         CE is available*!

 

 

HOTEL/VENUE

 

The beautiful W Hotel in Midtown Atlanta will be the venue for our Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!

 

MORE INFORMATION

 

Katie Witkiewitz, PhD, Co-Chair

Jennifer Buckman, PhD, Co-Chair

Jenna Cohen, Registration and Hotel Accommodations (202-682-5132)

 

 

 

*Continuing Education provided during the Collaborative Perspectives on Addiction Conference is provided by APA Division 50. APA Division 50 is approved by the American Psychological Association to sponsor continuing education for psychologists. Division 50 maintains responsibility for this program and its content. For more information on the available hours and learning objectives, contact jcohen@apa.org.

 

 

 

 

 

[DIV28SUPER] FW: Call for Proposals; APF 2014 Visionary, Barlow, and Weiss Grants

 

 

From: Carney, Erin [mailto:ecarney@apa.org]
Sent: Thursday, December 05, 2013 12:45 PM
Subject: Call for Proposals; APF 2014 Visionary, Barlow, and Weiss Grants

 

Dear Sir or Madam:

 

You are receiving this message because you are an APA division listserv owner.  Please find attached the Call for Proposals for the following 2014 American Psychological Foundation (APF) grants:

 

Ø  Visionary Grants: Grants range from $5,000 - $20,000

Ø  David H. and Beverly A. Barlow Grant: One grant of up to $7,000

Ø  Drs. Rosalee G. and Raymond A. Weiss Research and Program Innovation Grant: One grant of up to $1,000

 

The deadline for all three programs is April 1, 2014.  Please consider publishing this announcement in your next message and feel free to distribute this call as you see fit at your organization.

 

Best,

 

Erin Carney

Program Coordinator

American Psychological Foundation

750 First Street, NE

Washington, DC 20002

P: (202) 336-5873 I F: (202) 336-5812 I ecarney@apa.org

www.americanpsychologicalfoundation.org

 

APF: Transforming the future through psychology

 

2013-11-29

[DIV28SUPER] Nancy Mello PhD

Via CPDD@lists.vcu.edu

TO:                         The McLean Community

FROM:                  Scott L. Rauch, MD

                                President and Psychiatrist in Chief

DATE:                    November 26, 2013

RE:                          Nancy K. Mello

 

It is with deep sadness that I announce the death of Nancy K. Mello, PhD, director of McLean Hospital's Alcohol and Drug Abuse Research Center (ADARC) and professor of psychology (neuroscience) at Harvard Medical School. Dr. Mello passed away unexpectedly on Nov. 25. She was 78.

A dedicated and well-respected researcher and mentor, Dr. Mello along with her husband Jack H. Mendelson, MD, founded the ADARC at McLean Hospital nearly 40 years ago.

Dr. Mello was a pioneer in substance abuse research and her accomplishments in advancing our knowledge of the biological and behavioral aspects of substance abuse were truly impressive by any standards. She was passionately devoted to her work and it will have a long-lasting impact on the field of substance abuse.

Dr. Mello had a prolific publication record, authoring more than 400 original peer-reviewed articles in numerous biomedical journals, including Science, Nature, the New England Journal of Medicine, the American Journal of Psychiatry, Biological Psychiatry and the Journal of the American Medical Association.

Along with her husband, Dr. Mello was the first to study the biological, behavioral and social dynamics of alcohol self-administration and withdrawal in people suffering from alcoholism.  Their findings on loss of control and mood dysfunction as a result of drinking by alcoholics not only revolutionized scientific understanding of alcoholic drinking behavior, it also stimulated a new generation of behavioral and psychological researchers to apply experimental models to the study of alcoholism.

Mello's interest in substance abuse went beyond alcohol as she conducted research on marijuana and opiates.  In 1980, she and her husband published a landmark study in the journal Science indicating the potential use of buprenorphine for opioid dependence. The study became the foundation for work that 20 years later, resulted in new and more effective methods to treat patients addicted to opioids.

Dr. Mello earned both her bachelor's and doctoral degrees from Pennsylvania State University. After receiving a PhD in Clinical Psychology, Dr. Mello was a postdoctoral trainee in physiology at Harvard Medical School and in the Experimental Analysis of Behavior Laboratory with Dr. B.F. Skinner at Harvard University. Dr. Mello then joined the Stanley Cobb Laboratories for Psychiatric Research at Massachusetts General Hospital and built her first operant behavior laboratory. Subsequently, Dr. Mello entered federal service and directed the first Intramural Research Program of the National Institute of Mental Health's National Center for Prevention and Control of Alcoholism. She was also a Research Consultant to the Special Action Office for Drug Abuse Prevention of the Executive Office of the President.

In 1974, McLean Hospital recruited Dr. Mello and Dr. Mendelson  to spearhead its alcohol and drug abuse research program—a  program that flourished under their tremendous leadership, characterized by knowledge, hard work and scientific savvy. In its four decades, the ADARC's multidisciplinary research programs have expanded exponentially. The center now includes four laboratory divisions, which, since their founding, have been continuously funded by competitively obtained, peer-reviewed, federal grants and contracts.

A widely recognized authority and contributor to the science of addiction, Dr. Mello's guidance was often sought by others. She was a consultant to the President of the United States Jimmy Carter's Biomedical Research Panel, she was on the nominating committee for the Nobel Prize for Physiology and Medicine for 15 years, and served as chair of the National Institute of Drug Abuse Board of Scientific Counselors.

Dr. Mello served on 12 editorial boards and was the editor of Advances in Substance Abuse since 1980 and editor of Experimental and Clinical Psychopharmacology since 2005.

Dr. Mello was a luminary in the field of substance abuse research. Thanks to her vision and her dedication to mentoring the future generations of scientists, she will continue to have influence on the field of addictions research for years to come.

Please join me in offering condolences to Dr. Mello's friends, family and colleagues. She will be greatly missed by all. Arrangements for a memorial service are being planned and details will be announced as they become available.


2013-11-25

[DIV28SUPER] Online Research Request

***Apologies for Cross-Posting***


Dear Fellow Division 28 Colleagues,

Researchers from the Institutes for Behavior Resources (IBR) and Johns Hopkins University School of Medicine are conducting an online questionnaire study of purchasing preferences in the general public.  The purpose of this project is to help scientists develop Behavioral Economic methods to better understand decision-making and choice behavior.  These tools and the insights they produce may ultimately provide support for evidence-based policies that can help improve public health, safety, and security.
 
To participate in the study, you must be at least 18 years of age and currently living in the United States.  All information you provide is confidential and you may remain anonymous.  Total test time is approximately 10-20 minutes.  You must complete the survey in one session, and you can only complete the survey once.
 
Participation is completely voluntary and uncompensated, but you may choose to enter a raffle for a $20 Amazon.com gift card by submitting a valid email address.  If you submit a complete and valid survey and enter the raffle, your odds of winning a gift card are 1 in 100. 
 
 
To participate, you may access the survey directly by clicking this secure link:
 
Or visiting the IBR website:
 
Or the IBR Facebook page:


If so inclined, please feel free to share with family, friends, colleagues, and students who may be interested in contributing.  My colleagues and I thank you for your time and consideration, and wish you all the best for an enjoyable holiday season and a happy, healthy, and prosperous new year.


With Kind Regards,


Pete Roma
-------------------------------
Peter G. Roma, Ph.D.

Director, Applied Behavioral Biology Unit
Institutes for Behavior Resources

Adjunct Assistant Professor of Behavioral Biology
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine

proma@ibrinc.org | 410-752-6080

www.ibrinc.org

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

2013-11-22

[DIV28SUPER] Research Training In Drug Abuse Behavior at the University of Kentucky


NIDA/NIH (5T32 DA035200)

RESEARCH TRAINING IN DRUG ABUSE BEHAVIOR

UNIVERSITY OF KENTUCKY

 

Pre-Doctoral and Postdoctoral Research Fellowship Positions Available

 

The University of Kentucky is recruiting pre-doctoral and post-doctoral fellows for our program on Research Training in Drug Abuse Behavior. A Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant Award (T32 DA035200) supports the research-training program that is directed by Craig R. Rush, PhD and Hannah K. Knudsen, PhD. This training program offers translational and interdisciplinary research training on bio-behavioral factors in drug abuse at the pre-doctoral and post-doctoral level. The program is designed to prepare trainees for roles in which basic, clinical, and translational research is conducted on bio-behavioral factors in the prevention, cause, course, and treatment of drug abuse. Training faculty consist of 28 individuals drawn from seven different academic and research units of the University. Graduates of this program are actively involved in research, teaching, publishing articles, and becoming independent drug abuse researchers.

 

TO APPLY: Potential applicants should review the research interests of training program faculty online (http://www.mc.uky.edu/behavioralscience/research/nida.asp) and contact potential faculty mentors regarding training opportunities. A complete application includes: 1) a letter from the applicant describing their career objectives and how training in drug abuse behavior would further their goals (include tentative project title, abstract, aims, and the behavioral outcome measure); 2) a current curriculum vita (CV); 3) a copy of the graduate academic record (i.e., official transcript); 4) a letter from the proposed training faculty expressing their level of enthusiasm for the applicant; and 5) three letters of recommendation. The complete application should be submitted to Dr. Rush electronically via email as a single PDF. Letters of recommendation should be submitted separately but also electronically. The application deadline for current openings is April 15, 2014. 

 

Inquiries can be sent to Craig R. Rush, PhD (email: crush2@email.uky.edu) or Hannah K. Knudsen, PhD (hkknud2@uky.edu).

 

SELECTION CRITERIA: Consistent with the goals of the training program, evaluation of applicants will be based on: 1) relevant prior research experience; 2) prior publication record; and 3) commitment to an independent research career or other professional public health career. Applicants must be a US citizen or hold a permanent residency visa.


               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.